Veterinary Medicines

Lidocainhydrochlorid 2%

Authorised
  • Lidocaine hydrochloride monohydrate
Download as PDF

Product identification

Medicine name:
Lidocainhydrochlorid 2%
Active substance:
  • Lidocaine hydrochloride monohydrate
Target species:
  • Cat
  • Horse
  • Dog
Route of administration:
  • Perineural use
  • Intramuscular use
  • Subcutaneous use
  • Topical

Product details

Active substance and strength:
  • Lidocaine hydrochloride monohydrate
    20.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Perineural use
    • Cat
    • Horse
      • Meat and offal
        5
        day
      • Milk
        5
        day
    • Dog
  • Intramuscular use
    • Cat
    • Horse
      • Meat and offal
        5
        day
      • Milk
        5
        day
    • Dog
  • Subcutaneous use
    • Cat
    • Horse
      • Meat and offal
        5
        day
      • Milk
        5
        day
    • Dog
  • Topical
    • Horse
      • Meat and offal
        5
        day
      • Milk
        5
        day
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN01BB
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Available in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
  • Bela-Pharm GmbH & Co. KG
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bela-Pharm GmbH & Co. KG
Responsible authority:
  • Federal Office Of Consumer Protection And Food Safety
Authorisation number:
  • 6357796.00.00
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 2/09/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."